< Back to Front Page
Text size
–
+
Meeting their Fate
Remember the fanfare when Fate Therapeutics was launched last year?
The startup's goal is to capitalize on the promise of stem cells. To do that it gathered the leading lights of the field, including founders Dr. David Scadden of the Harvard Stem Cell Institute and Massachusetts General Hospital and Dr. Leonard Zon of Harvard University and Children's Hospital Boston. Robert S. Langer Jr. and Ram Sasisekharan of MIT sit on the scientific advisory board.
Find out on xconomy.com how venture capitalists brought them (and other stem-cell stars) together, including a fateful meeting at a French restaurant near Mass. General.
This blogger might want to review your comment before posting it.
about white coat notes We post updates every weekday about the region's hospitals,
labs and medical schools – covering everything from the latest research findings to
what's on the minds of the innovative doctors, nurses and scientists who work here.
Send news items and tips to whitecoat@globe.com
Contributors
blogger
Elizabeth Cooney covers health for the Worcester Telegram & Gazette. She
previously reported on business and was an editor at the paper. Earlier in
her career, she edited medical books and journals at Little, Brown, and
worked for Boston magazine.Boston Globe Health and Science staff:
- Karen Weintraub, Deputy Health and Science Editor
- Gideon Gil, Health and Science Editor
- Ishani Ganguli, Short White Coat blogger
- Joshua U. Klein, M.D., Short White Coat blogger
